James Preece

James is responsible for understanding global healthcare markets to inform FluoretiQ’s business development, commercialisation and tactical marketing strategies. He is able to translate his experience within SME, consultancy and drug discovery environments to ensure NANOPLEX™ is part of the solution to tackling Antimicrobial Resistance.